The effect of nitric oxide on glucose metabolism

Molecular and Cellular Biochemistry

Volumn 263, Issue 1, 2004, Pages 29-34

  Ragoobirsingh, Dalip ^a   McGrowder, Donovan ^a   Dasgupta, Tara ^a   Brown, Paul ^a  

^a UNIVERSITY OF THE WEST INDIES   (Jamaica)

Author keywords

Average receptor affinity; Insulin receptor sites per cell; Mononuclear leucocytes; Nitric oxide; S nitrosoglutathione

Indexed keywords

CAPTOPRIL; GLUCOSE; INSULIN; NITRIC OXIDE; S NITROSOGLUTATHIONE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BINDING AFFINITY; CELL MEMBRANE; CONTROLLED STUDY; DIABETES MELLITUS; DIABETOGENESIS; DOG; EVIDENCE BASED MEDICINE; FEMALE; GLUCOSE METABOLISM; MALE; MONONUCLEAR CELL; NONHUMAN; QUANTITATIVE ANALYSIS; RECEPTOR BINDING; SIGNAL TRANSDUCTION;

ANIMALS; BINDING, COMPETITIVE; CAPTOPRIL; CELL MEMBRANE; DIABETES MELLITUS, TYPE 2; DOGS; FEMALE; GLUCOSE; INSULIN; KINETICS; LEUKOCYTES, MONONUCLEAR; MALE; NITRIC OXIDE; NITRIC OXIDE DONORS; RECEPTOR, INSULIN; S-NITROSOGLUTATHIONE;

CANIS FAMILIARIS;

EID: 4544373603     PISSN: 03008177     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:MCBI.0000041846.99698.5d     Document Type: Article

References (27)

1. Moncada S, Palmer RMJ, Higgs EA: Nitric oxide: Physiology, pathophysiology, and pharmacology. Pharmacol Rev 43: 109-142, 1991
2. Singh R, Hogg N, Joseph J, Kalyanaraman B: Mechanism of nitric oxide release from s-nitrosothiols. J Biol Chem 27: 18596-18602, 1996
3. Myers P, Minor RL Jr, Guerra R Jr, Bates JN, Harrison DG: Vasorelaxant properties of the endothelium-derived relaxing factor more closely resembles S-nitrosocysteine than nitric oxide. Nature (Lond) 345: 161-163, 1990
4. Konorev EA, Tarpey MM, Joseph J, Baker JE, Kalyanaraman B: S-nitrosoglutathione improves functional recovery in the isolated rat heart after cardioplegic ischaemic arrest - Evidence for cardioprotective effect of nitric oxide. J Pharmacol Exp Ther 274: 200-206, 1995
5. Macallister RJ, Calver AL, Riezebos J, Collier J, Vallance P: Relative potency and arteriovenous selectivity of nitrovasodilators on human blood vessels: An insight into targeting of nitric oxide delivery. J Pharmacol Exp Ther 273: 154-160, 1995
6. Langford EJ, Brown AS, Wainwright RJ, De Belder AJ, Thomas MR, Smith REA, Radomski MW, Martin JF, Monocada S: Inhibition of platelet activity by S-nitrosoglutathione during coronary angioplasty. Lancet 344: 1458-1460, 1994
7. McGrowder D, Ragoobirsingh D, Dasgupta T: The hyperglycemic effect of S-nitrosoglutathione in the dog. Nitric Oxide 3(6), 481-491, 1999
8. Roth J: Peptide hormone binding to receptors: A review of direct studies in vitro. Metabolism (Clin Exp), 22: 1059-1073, 1973
9. Kasuga M, Zick Y, Blithe DL, Crettaz M, Khan CR: Insulin stimulates tyrosine phosphorylation of the insulin receptor in a "cell-free" system. Nature 298: 667-669, 1982
10. Hart TW: Some observations concerning the S-nitroso and S-phenylsulphonyl derivatives of L-cysteine and glutathione. Tetrahedral Lett 26: 2013-2016, 1985
11. Ghambir KK, Archer JA, Bradley CJ: Characteristics of human erythrocyte insulin receptors. Diabetes 27: 701-708, 1978
12. Ghambir KK, Archer JA, Carter L: Insulin radioreceptor assay for human erythrocytes. Clin Chem 23: 1590-1595, 1977
13. Scatchard G: The attraction of proteins for small molecules and ions. Ann NY Acad Sci 51: 660-672, 1949
14. DeMeyts P, Roth J, Neville DM Jr, Gavin JR, Lesniak MA: Insulin's interactions with its receptors - Experimental evidence for negative cooperativity. Biochem Biophys Res Commun 55: 154-165, 1973
15. LeFloch JP, Escuyer P, Baudin E, Baudon D, Perlemuter L: Blood glucose area under the curve: Methodological aspects. Diabetes Care 13: 172-175, 1990
16. Godfrey K: Statistics in practice: Comparing the means of several groups. N Engl J Med 313: 1450-1456, 1985
17. Caro JF, Sinha MK, Raju SM, Ittoop O, Pories WJ, Flickinger EG, Meelheim D, Dohm GL: Insulin receptor kinase in human skeletal muscle from obese subjects with and without non-insulin dependent diabetes mellitus. J Clin Invest 79: 1330-1337, 1987
18. Li J: Nitric oxide synthase (NOS) co-exist with activated neurons by skeletal muscle contraction in the brainstem of cats. Life Sci 24: 2833-2843, 2002
19. Khan CR, Freychet P, Roth J: Quantitative aspects of the insulin-receptor interaction in liver plasma membranes. J Biol Chem 249: 2249-2257, 1974
20. Segal SS: Nitric oxide release is present from incubated skeletal muscle preparations (Editorial). J Appl Physiol 77: 2517-2518, 1994
21. Kapur S, Bedard S, Marcotte B, Cote CH, Marette A: Expression of nitric oxide synthase in skeletal muscle: A novel role of nitric oxide as a modulator of insulin action. Diabetes 46: 1691-1700, 1997
22. Harmon JT, Khan CR, Kempner ES, Schlegel W: Characterization of the insulin receptor in its membrane environment by radiation inactivation. J Biol Chem 255: 3412-3419, 1980
23. Massague J, Czech MP: Role of disulphides in the sub-unit structure of the insulin receptor. J Biol Chem 257: 6729-6738, 1982
24. Slater TF: Free radical mechanisms in tissue injury. Biochem J 22: 1-15, 1984
25. Dons RF, Corash LM, Gorden P: The insulin receptor is an age-dependent integral component of the human erythrocyte membrane. J Biol Chem 256: 2982-2987, 1981
26. Soll AH, Goldfin ID, Roth J, Kahn CR: Impairment of insulin binding to the fat cell membranes in the obese hyperglycaemic mouse. FEBS Lett 25: 339-342, 1972
27. Olefsky JM, Jen P, Reaven GM: Insulin binding to isolated human adipocytes. Diabetes 23: 565-571, 1974